With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. After charting similar moves ...

LONDON - British drugmaker GSK spun off its consumer health business on Monday in the biggest listing in Europe for more than a decade, but the unit's market value of 30.5 billion pounds fell well ...

GSK plc (NYSE:GSK) confirmed the sale of 385.3 million shares in Haleon plc (NYSE:HLN) for $1.58 billion. The shares represented around 4.2% of the issued share capital of Haleon. Following the ...

May 17 (Reuters) - British drugmaker GSK (GSK.L), opens new tab has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon (HLN.L), opens ...

London-based consumer healthcare group Haleon Plc (NYSE:HLN) stock is trading lower on Thursday. Haleon, GSK Plc’s (NYSE:GSK) spun off, reported revenue of 11.23 billion pounds (US$14.19 billion) for ...

GSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the consumer health company. About 385 million shares will be sold at a ...

GSK (NYSE:GSK) said on Tuesday it has agreed to sell 300M shares of Haleon (NYSE:HLN) for gross proceeds of approximately £978M, or $1.2B. The British drugmaker's announcement came after a report ...

Oct 5 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Thursday it intends to sell a 2.9% stake, or about 270 million shares, in its spun-off consumer healthcare business Haleon (HLN.L ...

A new company, Haleon, now sells dozens of products from what was formerly GSK's huge consumer health division, which was spun off in 2022. The company pretends to be highly ethical in its website ...

Jan 16 (Reuters) - GSK GSK.L will sell a 3.2% stake, or about 300 million shares, in its spun-off consumer healthcare business Haleon HLN.L, the British drugmaker said on Tuesday. The announcement ...

GSK Plc has raised £886 million ($1.1 billion) from the latest sale of a tranche of shares in Haleon Plc, the consumer-health business it spun off last year. The British drug company sold 270 million ...